CSAR lecture: Using the very small to tackle the very large

Speaker: Professor Dame Ijeoma Uchegbu DBE FMedSci HonFRSC, Wolfson College, Cambridge; UCL School of Pharmacy, London; Nanomerics Ltd, London.
Series: Cambridge Society for the Application of Research (CSAR)
Admission (organiser's words): Open to all.
Note: Please note: this will be held at the Old Divinity School, St. John's Street, rather than at Churchill College

Our nanomedicine journey from concept to clinic.

Drug development is expensive and risky, with a 0.02% chance of success from concept to the market and with costs of about one billion US dollars. Inadequate efficacy is a major reason for failure and low concentrations of drug at the site of disease contribute to poor effectiveness.

An estimated half of patients with chronic conditions do not take their medicines as prescribed due to the fear of side effects. Side effects may be minimised if more drug is channelled away from healthy tissue and towards diseased tissue.

The talk will explore some solutions to the efficacy and side effects issues.

Open to all. See https://www.csar.org.uk/lectures/ for more details. Book at BookWhen.